Cancer Institute A national cancer institute
designated cancer center

April 2011 Cancer Center Bulletin

Director's Update

The annual member retreat is April 11 at the Quadrus Center.  We are expecting an exciting day with interactive panels, break out groups, and a few formal talks.

We are announcing a new round of seed grant applications this month.  The application materials can be found at are also be announcing new awards from the Jimmy V Foundation (see below).



Cancer Prevention Institute of California Newsletter

Key Dates

April 11, 2011

Stanford Cancer Center Members’ Retreat
Quadrus Conference Center

May 7, 2011

"Each One Reach One"
The Cancer Prevention Institute of California is hosting its 7th Annual African American Breast Cancer Conference, a program for and about the community that is intended to help raise awareness about breast cancer and the importance of early detection in African American communities in the Greater San Francisco Bay Area and surrounding communities. The Stanford Cancer Center is a major sponsor of this event. The conference will be held at, The Cathedral of Christ 
the Light
2121 Harrison Street
Oakland, CA 94612. For further details go to,

May 28, 2011

Canary Century Bike Event, benefiting the Stanford Cancer Center.  For registration and more information visit




Grant announcements are also distributed to Cancer Center members via email. For additional information, please contact Denise Baughman at

The Cancer Center has announced the application process for Developmental Cancer Research Awards (DCRAs).  The DCRA program provides multiple $50,000 seed grants for new ideas in translational and population science research. It provides one $100,000 grant for ideas that fosters interactive research projects.  The deadline is May 26.  Application forms are available at

The Jimmy V Foundation has announced the availability of a $600,000 grant ($200,000 per year over 3 years) for an unfunded translational research project that brings together pre-clinical and clinical investigation. Its purpose is to develop novel approaches to the prevention, detection, and treatment of human cancer that requires collaboration of investigators from the lab and the clinic. The project team must have a minimum of two investigators from the same facility and the team must possess both basic science and clinical expertise. The proposal deadline is June 10, 2011 and the proposal (10 page maximum) must be submitted by the Cancer Center.

I encourage any interested team to submit a one-page proposal giving the names of the investigators, title of the project, and a several paragraph summary of the proposal to Denise Baughman by Thursday, April 14. A small committee will decide which proposal should go forward based on merit and we will notify everyone by April 29, 2011.

The Jimmy V Foundation has also invited the Stanford Cancer Center to nominate a junior faculty member for the V Foundation Scholar Award. Each grant will total $200,000, and is given in two yearly installments. This grant has a zero indirect cost policy, and funds are to be used to offset the direct costs of the research project.

The grant is designed to identify, retain and further careers of talented young investigators. Provides funds directly to young scientists who are developing their own independent laboratory research projects. These grants enable talented young scientists to establish their laboratories and gain a competitive edge necessary to earn additional funding from other sources. The V Scholars determine how to best use the funds in their research projects.

The V foundation Scholar candidate must:

o Be associated with a non-profit institution
o Demonstrated expertise and promise in the designated areas of research
o Completed at least two years of fellowship training
o Must currently hold a tenured track faculty position
o No more than 10 years since terminal degree (M.D. or Ph.D.)
      (Exceptions must be approved prior to submission)
o Not been promoted to Associate Professor

Researchers who have secured their own R01 funding are not eligible for this award. Applicants with institutional or K08 awards are eligible.

The V Foundation proposal deadline is Friday, August 5, 2011.  For more information, please refer to the V Foundation website:

I encourage any interested investigator to submit a one-page letter, describing your research project to Denise Baughman ( ) by Monday, June 6, 2011 . A small committee will decide which proposal should go forward based on merit and we will notify everyone within 5 days of making the final decision.

KUDOS Blau, PhD, Donald E. and Delia B. Baxter Professor, Microbiology & Immunology - Member, Bio-X Member and Cancer Center Member has been honored by the American Association for Cancer Research (AACR) to deliver the Irving Weinstein Foundation Distinguished Lectureship on Saturday April 2 at the annual AACR meeting.    The lectureship was established to acknowledge an individual whose outstanding innovations in science and whose position as a thought leader have the potential to inspire creative thinking and new directions in cancer research.  This Lectureship is selected by the AACR President, and is not open to nomination. Blau's lecture, "(Re)-evolutionary Regenerative Medicine," will take place at 5:30 p.m. ET on Saturday, April 2 in room W320 of the Orange County Convention Center.

Professor Philip Hanawalt has received the Princess Takamatsu Lectureship Award from the American Association for Cancer Research. The AACR Princess Takamatsu Memorial Lectureship was established and first presented in 2007 in honor of the late Princess Takamatsu of Japan. This lectureship recognizes an individual scientist whose novel and significant work has had or may have a far-reaching impact on the detection, diagnosis, treatment, or prevention of cancer, and who embodies the dedication of the Princess to multinational collaboration.  Dr. Hanawalt will deliver his lecture entitled, Transcription, DNA Repair and Cancer, at the AACR 102nd Annual Meeting 2011 in Orlando, FL. The award ceremony and lecture will be held on Monday, April 4, 2011, from 3:30 p.m.-4:30 p.m.

Ron Levy, M.D. Professor of Medicine (Oncology) and Associate Cancer Center Director for Translational Research, has led a successful effort for Stanford to become a member site in the Cancer Immunotherapy Trials Network (CITN)The purpose of CITN is to stimulate the conduct of early (Phase I and Phase II) clinical trials.  The emphasis is on clinical trials of “high priority” agents that were identified at the 2007 NCI immunotherapy agent workshop and on clinical trials using combinations of immunotherapy modalities and other agents.

Jean Tang, M.D., Ph.D., Assistant Professor of Dermatology has led a study to be presented at the Opening Plenary Session of the American Association for Cancer Research this Sunday in Orlando, Florida. Tang is presenting results of an investigator-initiated, randomized controlled trial testing a new inhibitor of the Hedgehog signaling pathway (GDC-0449), which drives the development of basal cell carcinomas (BCC) of the skin.




Smoking Cessation
Apr 01, 2011 (Fri) - | Medicine
Li Ka Shing Learning Knowledge Center : Stanford, CA
Maximum Number of Credits: 7.00  AMA PRA Category 1 Credits

Breast Cancer Grand Rounds: 18F FPPRGD2: A Novel PET Radiopharmaceutical for Imaging Integrin Expression
Apr 01, 2011 (Fri) | 2:00 PM -2:50 PM
Cancer Center, CC2103 : Stanford, CA
Department:  Cancer Center
Contact: Jaclyn Salonga | 1-2418 |

Hedgehog-Gli Signaling in Cancer Stem Cells and Metastases
Apr 05, 2011 (Tue) | 12:00 PM -1:30 PM
Munzer Auditorium : Stanford, Ca
Department:  Cancer Biology
Contact: Elizabeth Colvin | 724-7185 |

" Epidemiology Studies of Colorectal Cancer”, Robert Sandler, MD, MPH UNC
Apr 06, 2011 (Wed) | 4:30 PM -5:30 PM
LKSC 130 291 Campus Drive : Stanford, CA
Department:  Gastroenterology & Hepatology
Contact: Elaine Tschorn | 650-721-6190 |

CCNE Nano-Bio Seminar Series: Nanobeacons for Cancer Imaging and Therapy
Apr 19, 2011 (Tue) | 4:30 PM -6:00 PM
TBD Contact Billie Robles : Stanford, CA
Department:  Molecular Imaging Program at Stanford (MIPS)
Contact: Billie Robles | 60196 |

FRONTIERS IN GENE & MOLECULAR THERAPIES - JOSHUA MENDELL, M.D., Ph.D. "MicroRNA reprogramming by oncogenic and tumor suppressor pathways"
Apr 21, 2011 (Thu) | 3:00 PM -4:00 PM
Munzer Auditorium, Beckman Center : Stanford, CA
Department:  Pediatrics
Contact: Mark A. Kay, M.D., Ph.D. | 650-498-6531 |


Stanford Medicine Resources:

Footer Links: